Objective This study aimed to examine the antifungal activity of -poly-L-lysine (-PL) against 10 the planktonic cells or biofilms of Candida albicans and explore the underlying mechanism. 11
Introduction 40
Candida albicans, also known as Canadian albicans, is widely found in nature, and is often 41 parasitic on human skin, mucous membranes, oral cavity, upper respiratory tract, and vagina [1] [2] . 42
Nowadays, with the increase in the number of immunocompromised patients and patients with 43 medically implanted devices (catheters, heart valves, cardiac pacemakers, vascular bypass grafts, 44 endotracheal tubes, and central nervous system shunts), fungal infection has become an important 45 issue that cannot be ignored in clinical practice, and Candida disease, represented by C. albicans, 46 is a hot issue [3] . According to statistics, C. albicans is the fourth largest pathogen of systemic 47 infection in the United States, with a mortality rate of up to 50% [4] . Although people are trying to 48 curb this situation, due to delayed diagnosis and antifungal resistance, candidiasis is associated 49 with high mortality worldwide. The last two decades have seen a growing trend toward the failure 50 of current antifungal drugs attributed to Candida biofilms [5] [6] . Under appropriate conditions, 51 adherence and colonization of planktonic cells on host tissues and medical devices initiate 52 multicellular organization called biofilm, which is an organized heterogeneous mixture of yeast, 53 hyphae, and pseudohyphal forms embedded in a complex extracellular matrix [7] [8] . Compared with 54 the planktonic cells, biofilms show high resistance to a wide variety of antifungal agents and 55 tolerance to harsh environments and host immune system [9] . Moreover, the development of 56 antifungal drugs is costly, long-term, and difficult. Thus, researchers turned their attention to 57 natural antibacterial peptides, hoping to find an effective antifungal substance or enhance the 58 sensitivity of the existing antifungal drugs to C. albicans [10] . 59
Antibacterial peptides, a class of natural antimicrobial substances, show anti-adhesive and 60 antimicrobial activities. Particularly, ε-poly-L-lysine (ε-PL) has a broad antibacterial spectrum, 61 high heat resistance, and good antibacterial action, even in acidic or alkaline medium. Especially, 62 it has bacteriostatic effects on Gram-negative bacteria, such as Escherichia coli and Salmonella, 63 which are not inhibited by other natural preservatives (such as nisin and natamycin) [11] . As early as 64
2003, Food and Drug Administration （FDA） approved it as a new type of natural food preservative, 65 and related research focused on its antibacterial properties and production and purification 66 techniques as preservatives. Only a few publications mentioned that ε-PL could strip the outer 67 membrane and cause an abnormal distribution of the cytoplasm [12] . Although some studies have 68 been carried out on the antifungal mechanism of -PL, none exhibited the specific molecular 69 mechanism of ε-PL on fungi [13] . To promote the application of ε-PL, elucidating its antibacterial 70 mechanism is particularly important. This study aimed to confirm the antibacterial activity of -PL 71 against C. albicans and its inhibitory effect on C. albicans biofilms. At the same time, its 72 antibacterial mechanism was initially explored for its clinical application, thus providing a 73 theoretical basis for new ideas and directions for clinical antifungal drug research and 74
development. 75

Methods 76
Strain and growth conditions 77
The standard strains of C. albicans, ATCC 64548 and ATCC 64550, were purchased from 78
American type cell culture (ATCC). Clinical isolates (CA1-50) were purified from vaginal, fecal, 79 sputum, and lavage fluid samples, which were identified by Matrix-assisted Laser 80
Desorption-ionization Time of Flight Mass Spectrometry (MALD-TPF-MS). All strains were 81
routinely grown in Sabouraud Dextrose Agar (SDA) at 30°C in a shaking incubator. 82
Antifungal susceptibility in vitro 83
The minimal inhibitory concentrations (MIC) of ɛ-PL against all the 52 strains were determined 84 according to the broth microdilution protocol of Clinical and Laboratory Standards 85
Institute(CLSI)with minor modifications [14] . Briefly, the initial fungal suspension used for 86 inoculation was adjusted to 10 3 CFU/mL in the Roswell Park Memorial Institute-1640 medium 87 and the final concentrations of ɛ-PL were adjusted from 16 to 4096 g/mL. The plates were 88 incubated at 37°C for 48 h. Growth inhibition was determined using optical density at 490 nm(OD 490 ), from which the background ODs were already subtracted. The MIC 80 was defined as the 90 concentration of drugs that inhibited 80% of the cell growth. Each strain was tested in triplicate 91 with positive and negative growths and drug controls. 92
Antibiofilm susceptibility in vitro 93
The antibiofilm effect of ɛ-PL was measured using crystal violet (CV) as described in a study by 94
Feng with minor modifications [15] . Briefly, 96-well plates were seeded with 200-μL aliquots of 2 95 × 10 3 CFU/mL fungal suspension and incubated statically at 37°C for 1.5 h for initial adhesion. 96
Then, the 96-well plates were washed slightly with phosphate-buffered saline (PBS; pH 7.2) to 97 remove nonadherent cells. A fresh RPMI-1640 medium with different concentrations of -PL was 98 added, followed by another 24 h of incubation. Then, the cells were crystallized after dry fixation 99 for 3 h, followed by rinsing with flowing distilled water until the medium was colorless. The cells 100
were then dried for 2 h, and 150 μL of 30% glacial acetic acid was added to each well. Growth 101 inhibition was determined using a spectrophotometer. OD 590 was measured, and the sessile 102 minimal inhibitory concentration (SMIC 50 ) was defined as the concentration of drugs that 103 inhibited 50% of cell growth. 104
Time-kill curve assay 105
For the time-kill curve assay, the C. albicans cells (ATCC64548 and ATCC64550) in the 106 exponential growth phase were resuspended in saline and adjusted to 5 × 10 4 CFU/mL. Different 107 concentrations of ɛ-PL formulated with the RPMI-1640 medium were added to the suspensions. 108
The samples were cultured at 37°C under constant shaking (200 rpm), and small aliquots were 109 withdrawn at predetermined time points (0, 3, 6, 9, and 12 h). The experiments were performed in 110 triplicate [16] . 111
In vitro antibiofilm assay 112
To determine the in vitro assay of ε-PL against mature biofilms, C. albicans cells (ATCC64548 shaking at 37C and 75 rpm for 24 h. The degree of clarity of -PL against mature biofilms of C. 123 albicans was determined using the SMIC 50 method [17] . 124
To determine the effect of -PL on biofilm formation, biofilm biomass was indirectly measured 125 using CV staining (70). After incubating the preserved cells at 37°C for 90 min, the biofilm was 126 washed three times with sterile PBS to remove unattached cells. ɛ-PL was diluted to 11 different 127 concentrations and inoculated into the treated 96-well plates at working concentrations of 16, 32, 128 64, 128, 256, 512, 1024, 2048, and 4096 μg/mL. Then, a blank control group was set. After 129 sealing with a plastic paper and placing it in a fungal growth incubator at 35°C for 24 h, the 130 biofilm formation was measured using the CV method. The experiment was performed in 131 triplicate, and the mean absorbance of each well was plotted against the -PL concentration. 132
Confocal laser scanning microscopy 133
The C. albicans ATCC64548 was cultured on the SDA medium overnight and then inoculated in 134 the YPD liquid medium at 35°C and 200 rpm. The culture was shaken to log phase, and after 135 collecting the cells, the physiological saline was used to prepare suspensions of 2 × 10 6 CFU/mL. 136
The prepared bacterial suspension was added to a laser confocal culture dish for 37 min at 37°C 137 and 200 rpm and then washed two to three times with PBS. Then, 1 mL of RPMI-1640 liquid 138 medium and 1 mL of different concentrations of -PL were added. Suspensions with different 139 working concentrations of -PL (0, 256, 512, and 1024 μg/mL) were cultured at 37°C for 24 h. 140
Then, the cells were co-stained with 10 μg/mL fluorescein diacetate (FDA) and 10 μg/mL 141 propidium iodide (PI) at 37°C for 45 min in the dark. Images were taken using a confocal laser 142 scanning microscope (CLSM). 143
Filamentation assay 144
The activated C. albicans ATCC64548 was formulated into 2 × 10 5 CFU/mL using physiological 145 saline and then inoculated separately in the RPMI-1640, YPD liquid containing 10% serum, and 146
Spider media. Different concentrations of -PL were added to the bovine serum to make working 147 concentrations of 0, 1/4 MIC, 1/2 MIC, MIC, and MFC at 37°C for 3, 6, and 9 h. The morphology 148 of the mycelium was detected using an inverted microscope. Each experiment was repeated three 149
times. 150
Measurement of intracellular reactive oxygen species 151
The intracellular reactive oxygen species (ROS) in C. albicans ATCC64548 biofilm cells was 152 measured using 2,7-Dichlorodi -hydrofluorescein diacetate (Sigma, the US) as described in a 153 previous study [19] . Briefly, the ɛ-PL-treated cells were pooled by centrifugation (3000 g, 5 min), 154 resuspended in sterile PBS to a final concentration of 6 × 10 6 CFU/mL, stained with DCFH-DA in 155 the dark at 37°C for 30 min, and finally analyzed using a fluorescence spectrophotometer (F-4500, 156 HITACHI Instrument, Tokyo, Japan). 157
Determination of lipid oxidation by treating C. albicans with ɛ-PL 158
To activate C. albicans ATCC64548, physiological saline configured to a concentration of 0.5 159
McMillan suspension was used. The strains were divided into groups A and B. Group A treatment 160 method was as described earlier. For group B, 10mM N-acetylcysteine (NAC) was added in group 161
A. The strains in the two groups were allowed to vortex at 37°C and 200 rpm for 12 h [20] . Then 162 they were centrifuged at 5000g for 5 min to collect the bacteria. Total protein was extracted using 163 the Yeast Protein Extraction Kit(Omega, China), and the protein concentration was measured 164 using the BCA Protein Assay Kit(Sangon Biotech, China). The lipid oxidation (malondialdehyde, 165 MDA) test kit (Wanleibio, China)was used to determine lipid oxidation damage. Each set of 166 experiments was repeated three times. 167
Effect of ɛ-PL on the cell membrane of C. albicans detected by PI staining 168
After preserving the standard strains ATCC 64548 (fluconazole-sensitive strain) and ATCC 64550 169 (fluconazole-resistant strain) of C. albicans in the SDA medium, they were configured to 1  10 7 170 CFU/mL using physiological saline and diluted 200 times with an RPMI-1640 medium. Then, 171 different concentrations of -PL were added to 500 L of diluted bacteria solution, and, and the 172 working concentration was adjusted to 0, 256, 512, and 1024 μg/mL. After incubating for 12 h at 173 37°C, the cells were collected at 1000 rpm and washed two to three times with PBS buffer. They 174 were added to 250 μL of PBS and stained with 5 μg/mL PI at 30°C. The cells were then incubated 175 in a water bath for 2 h, centrifuged at 3000 rpm for 5 min, washed three times with sterile PBS, 176
and observed using a fluorescence microscope.
Quantification of gene expression by real-time reverse transcriptase-polymerase chain 178 reaction 179
Real-time reverse transcriptase-polymerase chain reaction (RT-PCR) was conducted for validating 180 the results derived from the RNA-seq (31). Total RNAs were isolated from the preformed biofilms 181 using the hot-phenol method. Approximately 1 g of total RNA was used to synthesize cDNA using 182 a ReverTra Ace quantitative PCR RT Kit (Toyobo Ltd., Osaka, Japan). Then, cDNA was diluted 183 After centrifuging the suspension and leaching it twice with PBS, 5-10 mg was added to a 1.5-mL 194 centrifuge tube containing 300 μL of sterile water and mixed well. Then, 900 μL of ethanol was 195 added, vortexed, and mixed. The mixture was centrifuged at 12,000 rpm for 3 min. The 196 supernatant was discarded and centrifuged at 12,000 rpm for 1 min. A pipette was used to aspirate 197 the supernatant, and the residual liquid was allowed to evaporate. Then, 50 μL of extract A was 198 added to the cell pellet, mixed with a pipette, and allowed to stand for 2 min at room temperature. 199
Glass beads were added and ground with a rod for 3 min. Extract B was added, vortexed and 200 mixed, and centrifuged at 12,000 rpm for 3 min. Then 1 μL of the supernatant was taken in a 201 pipette and added to the sample of the target plate at room temperature and allowed to dry. Next, 1 202 μL of the matrix solution was added to cover the sample, allowed to dry naturally, and tested on 203 the machine. The procedure was repeated 10 times. Mass spectrometry analysis was used to map 204 different groups of samples. 205
206
Results
208
Antifungal activity of -PL 209
Supplement Table 1 shows that -PL had a broad-spectrum antifungal ability, exerting a potent to 210 moderate killing effect, especially against the fluconazole-resistant strain. 211
The MIC 80 was between 256 and 512 g/mL against clinical isolates and standard strains (the 212 fluconazole-sensitive strain ATCC64548 and the fluconazole-resistant strain ATCC64550). The 213 time-kill assay showed that -PL inhibited the growth of C. albicans SC5314 cells in a 214 dose-dependent manner (Fig. 1) . A striking fact about the figures is that MIC and MFC resulted in 
221
-PL inhibits C. albicans biofilms in vitro 222
The CV method showed that ε-PL eradicated mature biofilms and inhibited biofilm formation (Fig.  223 2). ε-PL inhibited mature biofilm experiments. First, ε-PL effectively eliminated preformed mature 224 biofilms that had been allowed to grow for 24 h. The effect was dose-dependent (Fig. 2a) , and 225 almost all mature biofilms (92%) were removed when treated with 512 g/mL -PL. Second, the 226 biofilm formation test further revealed that the antibiotic membrane effect began at the initial 227 stage of biofilm formation. At 512 and 256 μg/mL concentrations of ε-PL, the biofilm inhibition 228 levels were close to 60% and 73%, respectively (P < 0.001). When cells were treated with higher 229 concentrations of ε-PL, no biofilm was formed (Fig. 2b) . 
240
The CLSM analysis further confirmed the anti-biofilm effect of ε-PL. The C. albicans biofilm in 241 the control group developed into a crossover network, and the hyphae swelled strongly as shown 242
in Figures 3a and 4a-4c . In the ε-PL treatment group, the degree of biofilm formation damage 243 correlated positively with the drug doses (Figs. 3b-3d and 4d-41 ). After treatment with 512 244 μg/mL ε-PL, the activity of hyphae decreased, as visualized using FDA labeling, and the 245 proportion of dead hyphae increased, as analyzed by CLSM (Fig. 3c) . 
-PL inhibits the C. albicans yeast-to-hypha transition 261
The hypha of C. albicans is an important virulence factor that plays an important role in the 262 pathogenesis. In this experiment, the phase transition of C. albicans yeast was observed using an 263 inverted microscope in bovine serum, YPD (10% serum), RPMI-1640, and Spider media for 4 h at 264 37°C. The results showed that the germination rate and length of C. albicans were significantly 265 inhibited by MIC and MFC concentrations, and the inhibitory effect was dose-dependent. The 266 results of the tube showed that the blank group was 4h after the microscope. A large number of 267 hyphae were observed, and the germination rate was low under MIC and MFC concentrations. 
306
Lipid oxidative damage to C. albicans by -PL 307
To further study the relationship between ROS and membrane oxidative damage of C. albicans, 308 the MDA content of C.albicans after different concentrations of ε-PL treatment was determined,and the MDA content after adding antioxidant NAC was determined. MDA was the major product 310 of membrane lipid peroxidation and one of the important signs of pressure on C. albicans 311 membrane system. By measuring the MDA production, it was safely concluded that different 312 concentrations of -PL caused lipid peroxidation of C. albicans membranes (Fig. 6) . After 313 treatment with 512 μg/mL technetium-PL, the MDA content was about seven times that of the 314 control group. Prior to the addition of antioxidants, the content of MDA positively correlated with 315 the concentration of p-PL. After adding the antioxidant, the MDA content significantly decreased. 
323
Effect of -PL on the cell membrane of C. albicans 324
In this study, the effect of -PL on the cell membrane integrity of C. albicans was determined 325 using the PI method. PI can enter the dead cells and bind to its DNA to form red fluorescence. 326
Measure the ROS reactive oxygen species produced byε-PL induced C. albicans by measuring 327 the fluorescence intensity of PI entering the cells.The results showed that compared with the 328 control group, the number of red fluorescent-labeled cells in the -PL treatment group increased 329 with the concentration of -PL. When the -PL concentration reached MFC, the ROS production 330 rate was about 93.7% (FIG 7.0) . 
344
Effect of -PL on the expression of oxidative stress genes in C. albicans 345
The RT-PCR analysis showed that the expression of oxidative stress genes Peroxisomal(PEX-28), 346 superoxide dismutase (SOD-1), Catalase(CAT-1)of C. albicans was upregulated by 347 2.4-fold ,2.6-fold and1.3-fold, respectively, after treatment of C. albicans with 512 g/mL -PL. 348 protein profiles at high and low concentrations were specific (FIG 9.0) . 378 -PL is recognized as a food preservative with broad-spectrum antibacterial activity. However, 388 only the inhibition of fungal growth by a single concentration of -PL has been reported so far [11] . 389
This study found that the MIC 80 and MFC of -PL inhibited the growth of planktonic cells of C. 390 albicans. Moreover, the time-kill curve indicated that -PL inhibited the growth of C. albicans, 391
including the fluconazole-sensitive strain ATCC64548 and fluconazole-resistant strain 392 ATCC64550, in a dose-dependent manner. Conazole-resistant strains showed no significant 393 difference. Previous studies showed that biofilm was an important virulence factor of C. albicans 394 and is also an important resistance factor [21] . The present study showed that the MIC 80 of -PL 395 significantly prevented the biofilm formation. The SMIC50 assay showed that the MIC of -PL 396 significantly inhibited the formation of biofilm, indicating that the inhibitory effect of -PL on 397 biofilm was more significant. Zeng [22] studied the biofilm inhibition of C. albicans in sulodexide 398 and showed that SMIC 50 was usually three to four times of MIC of planktonic bacteria, compared 399 with the inhibitory effect of -PL on biofilm in this study. 400
CLSM and optical microscope analysis of the C. albicans biofilm demonstrated that -PL 401 inhibited the formation of C. albicans biofilm in a dose-dependent manner (Fig. 1) . However, the 402 image of MIC 80 showed the presence of dense hyphae in the absence of -PL. The sequential 403 process of biofilm formation was as follows: the adhesion of yeast cells to the substrate, the 404 proliferation of these yeast cells, the formation of biofilms of mycelial cells, the accumulation of 405 extracellular matrix material, and the dispersion of yeast cells from biofilm complexes [23] . Hyphae 406 play an important role in the adhesion phase of biofilm formation [24] . Using light microscopy, the 407 yeast-to-hypha transformation of C. albicans against C. albicans was also compared in the 408 medium that induced mycelial formation, such as bovine serum, RPMI-1640, 10% serum YPD, 409
and Spider media. -PL showed a significant inhibitory effect. The hyphae-related experiments 410 clearly demonstrated that -PL had a significant inhibitory effect on the yeast-bacteria 411 transformation of C. albicans. It was believed that -PL reduced the hydrophobicity by inhibiting 412 yeast-to-hypha transformation, preventing biofilm formation, and exerting antibacterial activity [25] .
413
The present study confirmed that -PL acted on the cells, and the ROS active oxygen content in C. 414 albicans increased. This phenomenon also occurred when -PL acted on E. coli, which was similar 415 as other antifungal agents reported in the literature. [26] [27] . ROS is a class of highly reactive small and proteins in C. albicans to alter their structural and biological characteristics [28] . In this study, 425 PI was used to detect the degree of damage caused by -PL on the cell membrane. The results 426
showed that the degree of cell membrane damage of C. albicans increased with the increase in 427 -PL concentration. It was believed that -PL exerted an antibacterial effect on the bacteria mainly 428 by destroying the plasma membrane of the bacteria at high concentrations; at other low 429 concentrations, it acted through other mechanisms [28] . In this study, mass spectrometry was used to 430 confirm that the low and high concentrations of -PL had an effect on C. albicans; mass 431 spectrometry showed significant specificity. Other studies also demonstrated specificity at the 432 genetic level [29] .
433
To further investigate the antibacterial mechanism of -PL against C. albicans, the expression of 434 oxidative stress-related genes (PEX-28, SOD-1, and CAT-1) in C. albicans induced by -PL was 435 examined. PEX-28 is involved in peroxidase synthesis. It regulates the size and proliferation of 436 peroxisomes [30] . SOD-1 is an important gene of C. albicans against oxidative stress [31] . The CAT-1 437 gene encodes catalase to increase the anti-oxidative stress of C. albicans [32] . These three important 438 oxidative stress genes showed different degrees of upregulation in this study, indicating that -PL 439 exerted oxidative stress on C. albicans. The DNA damage repair response (SOS response gene) 440 showed a significant increase in NTG and APN genes. The DNA glycosidase encoded by the NTG 441 gene and the APN endonuclease encoded by APN are the major repair genes in the basal excision 442 repair pathway. Repair of DNA damage was caused by endogenous and exogenous ROS [33] ; the 443 expression of virulence genes ENO1 and HXK were downregulated in this study. The enolase 444 encoded by ENO1 gene is considered to be the main antigen in patients with candidiasis. 445
Moreover, it has the advantage of invasion when plasmin binding induces fibrinolysis [34] . The 446 HXK gene-encoded hexokinase is closely related to the transformation of C. albicans to themycelium form [35] . In conclusion, this study showed that -PL could inhibit the ability of C. 448 albicans to infect. 449
